Federal Trade Commission
FROM Richard Feinstein
Expiring Patents, Drug Prices and the Hazy Market for Generics Patents are about to expire on two of the world's best-selling prescription drugs. Prices for cholesterol-fighter Lipitor and the blood-thinner Plavix are likely to drop by 80 percent when they're replaced by generics. But that's not all. The drug industry will be faced with an unprecedented wave of expiring patents in the next few years. What will the expiration of patents on many other drugs mean for Big Pharma? How is the industry fighting back? Will consumers get the benefits they deserve?
Cover-up or witch hunt?: The latest on the WH ties to Russia Less than two months into his Presidency, Donald Trump is struggling to get his agenda under way, making it harder himself with tweets that dominate public attention. Meanwhile, important questions are going unanswered: why have staff members and the Attorney General lied about contacts with Russian officials?
The 'deconstruction' of the administrative state President Trump has failed to fill high-level positions in important agencies — and some people he has named want to phase out the agencies they're supposed to lead. We look at the possible consequences for delivering services and providing security — and at top aide Steve Bannon's plans for "deconstructing the administrative state."
Political appointments and the reshaping of the judiciary President Trump has the chance for a long-term impact -- not just on the US Supreme Court, but on the entire federal court system. And his nominees are likely to get the support of a massive spending campaign by donors who don't have to reveal their names. Can President Trump "pack" the federal court system?